Navigation Links
WallSt.net Updates Investment Community Through All-New Interview With Transplant Creations
Date:1/16/2008

NEW YORK, Jan. 16 /PRNewswire/ -- On January 10, Dr. Marlies Van Hoef, CEO of Transplant Creations (http://www.transplantcreations.com) updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company, recent press, the market opportunity and upcoming milestones for which investors should watch.

To hear the interview in its entirety, visit the Company website at http://www.transplantcreations.com or go to http://www.wallst.net/audio/audio.asp?ticker=PRIVATE&id=4341.

About Transplant Creations:

Experienced in evaluation of the therapeutic potential of products, Transplant Creations' service department provides advice in strategic planning during the preclinical stage of development, during early or late stage clinical development, or at a moment that companies consider acquisition or development of a product in a therapeutic area within our focus.

Specialized in hematopoietic stem cell transplantation with a focus on malignant diseases and a back-ground in oncology and hematology the Company has developed a unique "delivery method" for "drug combinations", autologous stem cell support and allogeneic hematopoietic stem cell grafting.

The investment sector has been focusing on drugs and technologies as targets for investment, said Van Hoef, we focus on method development through same clinical research principles as drug development.

Van Hoef emphasized that there is an opportunity for investment in methods that has remained unexplored. The Company's unique method offers superior perspectives for disease outcome.

The mission for 2008 and beyond is to invite investors and the public to get involved in implementation of the method.

For more information, please visit http://www.transplantcreations.com.

About WallSt.net:

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The Web site is a leading provider of timely business news, executive interviews, multimedia content and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a financial social network for investors, and Financial Filings Corp., a provider of compliance solutions to publicly traded companies. Additionally, WallStreet Direct, Inc. owns and operates WallStRadio, a business and finance podcast Web site. Financial Filings Corp. is expecting to receive two hundred eighty dollars from Transplant Creations for the dissemination of this press release. For a complete list of our advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

Contact: WallSt.net

800-4-WALLST


'/>"/>
SOURCE WallStreet Direct, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WallSt.net Announces Upcoming Interview With CEO of Avicena Group
2. WallSt.net Announces Upcoming Interview with CSO and COO of Urigen Pharmaceuticals
3. WallSt.net Announces Upcoming Interview With CEO of Alliance HealthCard
4. Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )
5. WallSt.net (www.wallst.net) Updates the Investment Community Through All-New Interviews With XMDC, POSS and TYPE
6. WallSt.net Updates Investment Community Through All-New Interview With XTend Medical
7. WallSt.net Updates Investment Community Through All-New Interview With Ingen Technologies
8. PPD Updates 2007 Forecast; Issues Financial Guidance for 2008
9. Cardiome Updates Guidance
10. Silverchair Learning Systems Updates and Develops New Courses
11. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Northridge ... now offering treatments for sleep apnea and TMJ at their office. TMJ, or ... , specifically the obstructive type, is increasingly being treated at dental offices with ...
(Date:3/24/2017)... ... March 24, 2017 , ... Viewers who like to educate ... historical facts, cultural practices, goods, services, and societal issues tend to appreciate and love ... the popular practice of utilizing running events for causes around the world. ...
(Date:3/24/2017)... ... March 24, 2017 , ... Judy Buchanan, ... Master in Frederick, MD. Judy says, “I am passionate about sharing Reiki as ... a very difficult and challenging time.” , A Certified Medical Reiki™ Master trained ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of Christian ... Bible teacher residing in North Carolina with his wife, Anna Marie. He and his ... six grandchildren. David is also the author of “Shadow and Substance.” , “Love, the ...
(Date:3/23/2017)... , ... March 23, 2017 , ... In 2016 the ... estimates that there could be four million Zika-related cases in the Americas within the ... numbers of US cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 Ascendis Pharma ... innovative TransCon technology to address significant unmet medical needs ... host a conference call and webcast on Monday, April ... Endocrine Society in Orlando, Florida , ... pipeline candidates (TransCon Growth Hormone, TransCon PTH and TransCon ...
(Date:3/23/2017)... DIEGO , March 23, 2017  A ... fast and accurate identification of individuals who carry ... risk for a rare yet potentially deadly side ... and bipolar disorder.  The gene HLA-B*15:02 ... reactions such as Stevens-Johnson syndrome and toxic epidermal ...
(Date:3/23/2017)... Prima BioMed has presented encouraging ... IMP321 in combination with Keytruda, with one of the ... a complete response. Recruitment in the second cohort is ... fully recruited by Q317. Preliminary efficacy data from the ... are expected mid-year (recruitment in the 226-patient Phase IIb ...
Breaking Medicine Technology: